Dopamine Hci In 5% Dextrose Injection, Solution
Product Images NDC 51662-1458

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dopamine Hci In 5% Dextrose (NDC 51662-1458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage 1 (Dosage 1)

This table displays the recommended infusion rates for efficient patient treatment based on their body weight. The table shows infusion rates (in ml/hour) per kg of body weight, for body weights ranging from 10 kg to 50 kg.*

FDA Label Image

Dosage 2 (Dosage 2)

This seems to be a table that shows the infusion rate in mg/kg/min based on patients' body weight. However, there seems to be a typo in the table on row three, where the 47 should be 4.7.*

FDA Label Image

Dosage 3 (Dosage 3)

This is a chart indicating infusion rates for patients of different body weights in kg. The chart lists the recommended infusion rates for specified body weights at the corresponding dosages in mg/kg/minute.*

FDA Label Image

How Supplied (How Supplied)

This is a list of Unit of Sale, Total Strength/Total Volume (Concentration) and NDC codes for a medication that comes in different strengths and volumes. The medication is sold in cartons of 12 and has different concentrations, ranging from 800 mcg/mL to 3200 mcg/mL.*

FDA Label Image

Iv Container Label (Iv Container Label)

The text seems to be a label of a medication bottle containing Dopamine HCI in 5% Dextrose Injection. The bottle has 800mg of medication in 500mL of solution, with a concentration of 1,600 meg/mL. No other information can be inferred from the text.*

FDA Label Image

Logo (Logo How Supplied)

FDA Label Image

Overwrap Label (Overwrap Label)

FDA Label Image

Precautions (Precautions)

This text provides instructions on how to prevent sloughing and necrosis in ischemic areas by using Regitine (phentolamine), an adrenergic blocking agent. The solution should be infiltrated throughout the ischemic area using a fine hypodermic needle as soon as possible after the extravasation is noted to cause immediate and conspicuous local hyperemic changes. The dosage for children is also specified.*

FDA Label Image

Serialized Labeling (Serialized Labeling Resized)

FDA Label Image

Structure 1 (Structure 1)

FDA Label Image

Structure 2 (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.